Angiotensin II Receptor Blockers Attenuate Lipopolysaccharide-Induced Memory Impairment by Modulation of NF-κB-Mediated BDNF/CREB Expression and Apoptosis in Spontaneously Hypertensive Rats
Authors:
- 18 February 2017
- journal article
- research article
- Published by Springer Nature in Molecular Neurobiology
- Vol. 55 (2) , 1725-1739
Abstract
Clinical studies demonstrated a positive correlation between hypertension and cognitive decline. Beneficial effects of angiotensin II receptor blockers on cognitive functions have also been reported earlier; however, its role in chronic neuroinflammation-induced memory impairment in the hypertensive state is not well understood. Therefore, in the present study, we investigated the effect of angiotensin II receptor blockers on memory impairment induced by lipopolysaccharide (LPS) in spontaneously hypertensive rats (SHRs). Our data provides the strong evidence that intracerebroventricular (ICV) administration of LPS (25 μg) on the 1st, 4th, 7th, and 10th days leads to sustained neuroinflammation (as indicated by increased TNF-α, GFAP, COX-2, and NF-κB) and oxidative stress (increased reactive oxygen species (ROS) and nitrite levels) resulting in amyloid beta (Aβ1–42) deposition, apoptosis (increased Bax and decreased Bcl-2 expression as well as increased caspase-3 activity and TUNEL-positive cells), and memory impairment. Further, we found that exaggerated inflammatory response and oxidative stress were associated with RAS over-activation (as evident from the increased ACE expression, angiotensin II (Ang II) level, and angiotensin type 1 receptor (AT1R) expression) and decreased BDNF and p-CREB expression. Oral administration of candesartan (an AT1R blocker) at a non-anti-hypertensive dose (0.1 mg/kg) for 15 days attenuated LPS-induced (ICV) apoptosis, amyloidogenesis, and memory impairment. Candesartan shows neuroprotection by inhibiting TLR4/Ang II-induced NF-κB inflammatory signaling and by enhancing associated BDNF/CREB expression in SHRs. Our study also demonstrated that when both AT1R and angiotensin type 2 receptor (AT2R) were blocked by candesartan and PD123319 concomitantly, the protective effects of candesartan were blunted suggesting that functionally active AT2R is required for beneficial effects of AT1R blockade.Keywords
Funding Information
- Indian Council of Medical Research (58/13/2010BMS)
This publication has 65 references indexed in Scilit:
- The Angiotensin II Type 2 Receptor in Brain Functions: An UpdateInternational Journal of Hypertension, 2012
- Glucocorticoid receptors recruit the CaMKIIα-BDNF-CREB pathways to mediate memory consolidationNature Neuroscience, 2012
- Midlife Blood Pressure, Plasma β-Amyloid, and the Risk for Alzheimer DiseaseHypertension, 2012
- Direct Stimulation of Angiotensin II Type 2 Receptor Enhances Spatial MemoryJournal of Cerebral Blood Flow & Metabolism, 2011
- Role of the angiotensin II AT2 receptor in inflammation and oxidative stress: opposing effects in lean and obese Zucker ratsAmerican Journal of Physiology-Renal Physiology, 2011
- Angiotensin II, a neuropeptide at the frontier between endocrinology and neuroscience: is there a link between the angiotensin II type 2 receptor and Alzheimer’s disease?Frontiers in Endocrinology, 2011
- Centrally administered lipopolysaccharide elicits sympathetic excitation via NAD(P)H oxidase-dependent mitogen-activated protein kinase signalingJournal Of Hypertension, 2010
- Hypertension and Cognitive FunctionClinics in Geriatric Medicine, 2009
- Up-regulating BDNF with an ampakine rescues synaptic plasticity and memory in Huntington's disease knockin miceProceedings of the National Academy of Sciences, 2009
- RETRACTED: Pyrrolidine dithiocarbamate attenuates the development of acute and chronic inflammationBritish Journal of Pharmacology, 2002